TAG:
laboratory executive
Preparing for the Unexpected and Unimagined
By R. Lewis Dark | From the Volume VI No. 6 – April 26, 1999 Issue
WHO WOULD HAVE EVER PREDICTED THAT A PHLEBOTOMIST would reuse needles? Just as surprising, who would have ever predicted that the phlebotomist would be working at a respected clinical laboratory like SmithKline Beecham Clinical Laboratories (SBCL)? …
Labs Entering New Cycle Of Evolution and Change
By Robert Michel | From the Volume VI No. 6 – April 26, 1999 Issue
CEO SUMMARY: As some of the nation’s most astute and forward-looking lab executives prepare to gather in New Orleans for the fourth annual EXECUTIVE WAR COLLEGE, it is time to share our assessment of the laboratory and pathology industry. Recent events presage another profound …
SBCL Phlebotomist Found Reusing Needles in Calif.
By Robert Michel | From the Volume VI No. 6 – April 26, 1999 Issue
CEO SUMMARY: News that a phlebotomist employed by SmithKline Beecham Clinical Laboratories (SBCL) was discovered to be washing and reusing needles got national media attention last week. During her 22-month employment at SBCL, this phlebotomist apparently reused butterfly needles on “di…
Unilab Signs Agreement To Buy Bio-Cypher Labs
By Robert Michel | From the Volume VI No. 6 – April 26, 1999 Issue
CEO SUMMARY: Unilab’s desire to purchase $60 million Bio-Cypher must be viewed against the impending acquisition by Quest Diagnostics of SmithKline Beecham Clinical Laboratories (SBCL). Whenever Quest takes control of SBCL’s lab operations, it automatically becomes a significant compe…
“April 26, 1999 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume VI No. 6 – April 26, 1999 Issue
Think turnover among laboratory executives and administrators is high? Get a load of this! Among CEOs at the nation’s 4,838 general, non-federal acute-care hospitals, the turnover rate was 16.9% during 1998. This was up from 12.1% in 1997. It means that one of every six hospitals got a new CEO last…
Client Service and Sales Fuel Fast Growth at AML
By Robert Michel | From the Volume VI No. 5 – April 5, 1999 Issue
CEO SUMMARY: Here’s proof positive that effective management can make a positive difference in the financial performance of clinical labs. Upon taking title to American Medical Laboratories in the spring of 1997, its new owners used an emphasis on “customer-first” service and aggres…
AutoCyte to Buy NSI’s Patents and Other Assets
By Robert Michel | From the Volume VI No. 5 – April 5, 1999 Issue
CEO SUMMARY: When Neuromedical Systems entered Chapter 11 bankruptcy, AutoCyte moved rapidly to purchase Neuromedical’s patents and other intellectual property for automated cytology technology. Even as Neuromedical disappears from the marketplace, AutoCyte is preparing its entry. Labor…
Unilab, DIANON Systems, UroCor Report 1998 Financial Results
By Robert Michel | From the Volume VI No. 5 – April 5, 1999 Issue
OPTIMISM REIGNS at California-based Unilab Corporation. Revenues are up, operating profits are increasing, and company officials are now talking about growth plans. For 1998, Unilab generated revenues of $217.4 million, compared to $214.0 million in 1997. …
Sales to Become the Secret Behind Successful Labs
By R. Lewis Dark | From the Volume VI No. 4 – March 15, 1999 Issue
SALES WILL BECOME A NECESSARY PART of every laboratory executive’s management toolbox during the next few years. The unmistakable success of the nation’s best-performing laboratories now rests on their effective use of sales and marketing programs. This is not something that most hospital labora…
Movers & Shakers For ’99 Demonstrate Leadership
By Robert Michel | From the Volume VI No. 4 – March 15, 1999 Issue
EACH YEAR IT BECOMES more difficult to make final selections for our annual Movers & Shakers awards. The reason is simple. Today there are more examples of leadership in the laboratory than when we first started these selections three years ago. This is a good omen. It means that the crucible of…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized